AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Business & Industry
- Pfizer and Lilly announce top-line results from long-term Phase 3 study of tanezumab in patients with osteoarthritis
- Roche reports a strong start in 2019 and raises the outlook for the full-year
- World Hemophilia Day: Sanofi Genzyme donation impacts patients across the globe
- Independent large real-world study comparing NOACs in AF-patients
- EVENITY™ (romosozumab-aqqg) now available in the United States for the treatment of osteoporosis in postmenopausal women at high risk for fracture
Research & Development
- Personalizing precision medicine with combination therapies improves outcomes in cancer
- Cannabidiol could help deliver medications to the brain
- High-dose vitamin D shows benefit in patients with advanced colorectal cancer
- One-third of cancer patients use complementary and alternative medicine
- Immune cells fighting blood cancer visualized for the first time
- Compound that kills drug-resistant fungi is isolated from ant microbiota
- First bacterial genome created entirely with a computer
Conferences & Events
- Last call for registrations to Pre-Filled Syringes East Coast conference
- Exclusive speaker interview with SCHOTT Pharmaceutical Systems released for Pre-Filled Syringes East Coast 2019
- Lyophilisation Conference 2019
- Pre-Filled Syringes West Coast conference 2019
- eyeforpharma Barcelona Conference, Expo & Awards 2019
- SMi presents the 2nd Annual Conference: Injectable Drug Delivery 2019
- 21st Annual Superbugs & Superdrugs Conference
Regulatory Affairs
- FDA permits marketing of first medical device for treatment of ADHD
- FDA approves first generic naloxone nasal spray to treat opioid overdose
- FDA approves first targeted therapy for metastatic bladder cancer
- FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture
- FDA expands approved use of metastatic breast cancer treatment to include male patients